May 05, 2021 / 12:00PM GMT
Operator
Good morning and welcome to Baudax Bio first-quarter 2021 financial results conference call. (Operator Instructions). As a reminder, this conference is being recorded at the company's request. I would now like to turn the call over to Claudia Styslinger, Investor Relations. You may begin.
Claudia Styslinger - Baudax Bio, Inc. - IR
Good morning and thank you for joining us on today's conference call to discuss Baudax Bio's first-quarter 2021 financial results. This is Claudia Styslinger and I am joined today by Gerri Henwood, President and Chief Executive Officer; and Rick Casten, Chief Financial Officer.
On today's call, Gerri will begin by providing some introductory remarks; Rick will then discuss the financial highlights from the quarter; and Gerri will follow with a business update and discuss the continued progress around the commercialization of ANJESO.
Earlier this morning, we issued a press release detailing our financial results for the first quarter of 2021. The press release along with the slide presentation that we will reference
Q1 2021 Baudax Bio Inc Earnings Call Transcript
May 05, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers